Below are the top drug related product stocks on the NYSE and the NASDAQ in terms of free cash flow.
The trailing-twelve-month free cash flow at Herbalife Ltd HLF is $230.7 million. HLF’s PEG ratio is 0.94.
The trailing-twelve-month free cash flow at NBTY Inc NTY is $153.2 million. Analysts at Barclays Capital upgraded NTY from “equal weight” to “overweight.”
The trailing-twelve-month free cash flow at Perrigo Company PRGO is $137 million. Analysts at Caris & Company upgraded PRGO from “average” to “above average.”
The trailing-twelve-month free cash flow at Salix Pharmaceuticals Ltd SLXP is $57.7 million. Analysts at Thomas Weisel initiated coverage of SLXP with an “overweight” rating.
Trading Ideas.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in